Skip to content
IFPMA Twitter
IFPMA LinkedIn
IFPMA Youtube
IFPMA Slideshare
IFPMA Flickr
IFPMA RSS
Search for:
Primary Menu
Who We Are
IFPMA in Brief
Our Governance and Leadership
Our Membership
Full Members
Associations
Companies
Affiliate Members
Our Experts
Join Us
Topics
News Center
News Releases
Blog
Global Health Matters
Science Matters
DG’s Column
Statements
Resources
Publications
News Releases
Statements
Position Papers
Publications
External Studies
Infographics
Event Highlights
Multimedia
Interviews
Videos
Slides
IFPMA Interactive Platforms
IFPMA COVID-19 Hub
Global Health Progress
50 Years of Global Health Progress
Events
Upcoming IFPMA Events
Geneva Pharma Forums
Assemblies
Other IFPMA Events
IFPMA in External Events
IFPMA Press Briefings
Past IFPMA Events
Geneva Pharma Forums
Assemblies
Other IFPMA Events
IFPMA in External Events
IFPMA Press Briefings
Partners
BCR
Inventing Medicines and Vaccines
Strengthening Regulatory Systems
Ethics and Business Integrity
Boosting Innovation and Access
Tackling Global health challenges
Climate change
Economic footprint
IP
Sustainable innovation
Value of innovation
spotlight
Value of innovation
African Medicines Agency
Biosimilars
Biotherapeutic medicines
Falsified medicines
Import testing
Pharmacovigilance
Quality, safety, and efficacy
Regulatory conferences
Regulatory system strengthening / Harmonization
Supply chain
The Africa Regulatory Network (ARN)
The ARN: Le réseau africain de réglementation pharmaceutique
spotlight
Pharmacovigilance
IFPMA Code of Practice (2019)
Our Ethos in Action
Our Ethos
Code eLearning Tool
IFPMA Notes for Guidance
IFPMA Complaint Operating Procedure
How to File a Code Complaint
Complaint Submission Form
Cases
Business Ethics for APEC SMEs Initiative
Consensus Framework for Ethical Collaboration
spotlight
IFPMA Code of Practice (2019)
Access to medicines
Global Policy Principles on Digital Health
Health technology assessment
IP
Technology Transfer
Trade
spotlight
Access to medicines
Ageing
Antimicrobial resistance
Cancer
Child and maternal health
COVID-19
Diabetes
Ebola
Falsified medicines
HIV/AIDS
Influenza
Malaria
Mental and neurological disorders
Neglected tropical diseases
Non-communicable diseases
Pandemic Preparedness
Public health implications of the implementation of the Nagoya Protocol
Rare diseases
Supply chain
Sustainable development goals
Tuberculosis
Universal Health Coverage
Vaccination confidence
Vaccines innovation
Vaccines protect communities
Vaccines sustainability
Value of immunization
Viral hepatitis
spotlight
Universal Health Coverage
Home
>
Tag: Innovation
Tag: Innovation
Brochure | HYPER Healthcare: Youth Perspectives. Empowered
Speak Up Africa and IFPMA launch the “Africa Young Innovators for Health Award” to fuel innovation and help advance promising healthcare solutions
Global Innovative Health Industries Alliance
IFPMA statement on “Intellectual Property and COVID-19”
HYPER | Healthcare: Youth Perspectives. EmpoweRed
IFPMA Policy Principles on COVID-19 Vaccines Initiative
Collaborating to end Neglected Tropical Diseases (Infographic)
Collaborating to end Neglected Tropical Diseases: Catalyzing Innovation and Partnerships
IFPMA Statement at Gavi Alliance Global Vaccine Summit 2020 (Video)
Pharma pledges to continue 20 year partnership with Gavi, the Vaccine Alliance
Biopharmaceutical Industry Statement at Gavi, the Vaccine Alliance – Global Vaccine Summit 2020
Generation Gavi: Partnering to protect health through life-saving vaccines
Infographic: Better Health Partnerships - Vaccines
Export Manufacturing Exemption during SPC/PTR Extended Patent Term: Global Position
Zika & Ebola: How global health threats prompt innovation (Visual recording of the panel discussion)
Access to medicines
Health technology assessment
Vaccines innovation
IFPMA facts & figures 2015
Biotherapeutic medicines
Economic footprint
"I am Innovation" (©IFPMA) (Portuguese subtitles)
IFPMA members' antibacterial compounds pipeline inventory 2015
7 Recommendations for a new economic model to incentivize innovation, meet preservation goals and ensure access to antibiotics
Pharmaceutical industry and global health
Maintaining the vaccines innovation edge
The Exciting journey of a vaccine
Eliminating roadblocks along the delivery route
IFPMA 2014 interview series 'What’s an innovation ecosystem from an industry perspective'
IFPMA 2014 interview Series: Andrew Jenner's take on 'Value of innovation'
1
2
Next »
Other Tags
Access
Access to antiretrovirals
Access to Medicines
Access to vaccines
Africa
AMR
AMR Industry Alliance
Anti-Counterfeit
Antibiotics
antimicrobial resistance
antivirals
Biosimilars
Biotherapeutic Medicines
Biotherapeutics
Cancer
Clinical Trials
Code of Practice
collaboration
Counterfeit Medicines
Counterfeits
COVID-19
COVID-19 vaccines
Dementia
Developing World
Diabetes
Economic footprint
Epidemics
Ethics
Event Highlights
Fake Medicines
Fakes
Falsified Medicines
Fight the Fakes
Flu
Global Health
global health security
harmonization
Health
Health Partnerships
HIV/AIDS
IFPMA
IFPMA Assembly
IFPMA Statement
Immunization
Incremental Innovation
Influenza
Infographic
Infographics
Innovation
Innovation ecosystem
Intellectual Property
IP
Malaria
MDGs
Medicines
Mental and Neurological Disorders
NCDs
Neglected Tropical Diseases
News Releases
Non-Communicable Diseases
Novel Coronavirus (COVID-19)
NTDs
pandemic
Pandemic Influenza
Pandemic preparedness
pandemics
partnership
Partnerships
Pharma
Pharmacovigilance
Position Paper
Prevention
Publications
Public Health
Quality
R&D
Regulatory
regulatory systems
Related Links
Research
Safety
SDGs
Seasonal Influenza
Statements
Supply chain
Sustainable Development Goals
Sustainable Innovation
trade
Treatments
Tuberculosis
UHC
Universal Health Coverage
Vaccine
Vaccines
Value of Innovation
Videos
WHA
WHO
WIPO
Women’s Cancers